201 related articles for article (PubMed ID: 9592619)
1. Pharmacokinetics and pharmacodynamics of hydroxyurea.
Gwilt PR; Tracewell WG
Clin Pharmacokinet; 1998 May; 34(5):347-58. PubMed ID: 9592619
[TBL] [Abstract][Full Text] [Related]
2. Development of a pharmacokinetic-guided dose individualization strategy for hydroxyurea treatment in children with sickle cell anaemia.
Dong M; McGann PT; Mizuno T; Ware RE; Vinks AA
Br J Clin Pharmacol; 2016 Apr; 81(4):742-52. PubMed ID: 26615061
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, safety and anti-human immunodeficiency virus (HIV) activity of hydroxyurea in combination with didanosine.
Luzzati R; Di Perri G; Fendt D; Ramarli D; Broccali G; Concia E
J Antimicrob Chemother; 1998 Oct; 42(4):565-6. PubMed ID: 9818769
[No Abstract] [Full Text] [Related]
4. Hydroxyurea: Analytical techniques and quantitative analysis.
Marahatta A; Ware RE
Blood Cells Mol Dis; 2017 Sep; 67():135-142. PubMed ID: 28847416
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for model-based precision dosing in the treatment of sickle cell anemia.
Dong M; Mizuno T; Vinks AA
Blood Cells Mol Dis; 2017 Sep; 67():143-147. PubMed ID: 28807656
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.
Wiczling P; Liem RI; Panepinto JA; Garg U; Abdel-Rahman SM; Kearns GL; Neville KA
J Clin Pharmacol; 2014 Sep; 54(9):1016-22. PubMed ID: 24729271
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profile of the anti-sickling hydroxyurea in wild-type and transgenic sickle cell mice.
Iyamu WE; Lian L; Asakura T
Chemotherapy; 2001; 47(4):270-8. PubMed ID: 11399864
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS).
Ware RE; Marahatta A; Ware JL; McElhinney K; Dong M; Vinks AA
J Pediatr; 2020 Jul; 222():236-239. PubMed ID: 32171562
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea as part of a salvage regimen for heavily pretreated patients with advanced HIV infection.
Grunke M; Dechant C; Löw P; Rascu A; Kalden JR; Harrer T
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):424-6. PubMed ID: 10458626
[No Abstract] [Full Text] [Related]
10. Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.
Estepp JH; Wiczling P; Moen J; Kang G; Mack JM; Liem R; Panepinto JA; Garg U; Kearns G; Neville KA
Br J Clin Pharmacol; 2018 Jul; 84(7):1478-1485. PubMed ID: 28884840
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
Obaro SK
Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
[No Abstract] [Full Text] [Related]
12. Treating sickle cell anaemia with hydroxycarbamide.
Pollack S
Br J Haematol; 2014 Jan; 164(2):296-7. PubMed ID: 24116862
[No Abstract] [Full Text] [Related]
13. Hydroxyurea for sickle cell anemia.
Naina HV; Harris S
N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
[No Abstract] [Full Text] [Related]
14. [Treatment with hydroxyurea has revolutionized the evolution of sickle cell disease ].
Bartolucci P; de Montalembert M
Rev Prat; 2014 Oct; 64(8):1127-8. PubMed ID: 25510141
[No Abstract] [Full Text] [Related]
15. Long-term use of hydroxyurea for sickle cell anemia.
Lee DA; Mueller BU
JAMA; 2003 Aug; 290(6):753-4; author reply 754. PubMed ID: 12915425
[No Abstract] [Full Text] [Related]
16. Hydroxyurea and new agents for the treatment of sickle cell disease.
Rodgers GP
Clin Adv Hematol Oncol; 2004 Nov; 2(11):713-5. PubMed ID: 16163257
[No Abstract] [Full Text] [Related]
17. Hydroxyurea for Sickle Cell Disease: Now Is the Time!
Strouse JJ
South Med J; 2016 Sep; 109(9):535-7. PubMed ID: 27598356
[No Abstract] [Full Text] [Related]
18. Hydroxyurea for the treatment of sickle cell anemia.
Platt OS
N Engl J Med; 2008 Mar; 358(13):1362-9. PubMed ID: 18367739
[No Abstract] [Full Text] [Related]
19. Hydroxyurea and sickle cell disease: a chance for every patient.
Weiner DL; Brugnara C
JAMA; 2003 Apr; 289(13):1692-4. PubMed ID: 12672739
[No Abstract] [Full Text] [Related]
20. Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea.
Singh SA; Koumbourlis AC; Aygun B
Pediatr Blood Cancer; 2008 Jun; 50(6):1258-60. PubMed ID: 18293380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]